A recent study investigates whether apixaban is superior to aspirin in preventing nonlacunar covert infarcts in patients with ...

Another Factor Xa inhibitor, apixaban, was investigated in the AVERROES trial, [11] and was compared with aspirin with respect to stroke prevention in 5599 patients with nonvalvular AF with >one ...

Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban) are necessary to assess the role of each agent in stroke prevention in patients with AF.